EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

JS Smolen, R Landewé, J Bijlsma… - Annals of the …, 2017 - ard.bmj.com
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

JS Smolen, R Landewé, FC Breedveld… - Annals of the …, 2010 - ard.bmj.com
Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear
and consensual international recommendations on RA treatment are not available. In this …

[HTML][HTML] Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review

BJE De Lange-Brokaar, A Ioan-Facsinay… - Osteoarthritis and …, 2012 - Elsevier
OBJECTIVE: Although osteoarthritis (OA) is considered a non-inflammatory condition, it is
widely accepted that synovial inflammation is a feature of OA. However, the role of immune …

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

D Aletaha, T Neogi, AJ Silman, J Funovits… - Arthritis & …, 2010 - Wiley Online Library
Abstract Objective The 1987 American College of Rheumatology (ACR; formerly, the
American Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

JS Smolen, RBM Landewé, JWJ Bijlsma… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …

Genetics of rheumatoid arthritis contributes to biology and drug discovery

Y Okada, D Wu, G Trynka, T Raj, C Terao, K Ikari… - Nature, 2014 - nature.com
A major challenge in human genetics is to devise a systematic strategy to integrate disease-
associated variants with diverse genomic and biological data sets to provide insight into …

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

EA Stahl, S Raychaudhuri, EF Remmers, G Xie… - Nature …, 2010 - nature.com
To identify new genetic risk factors for rheumatoid arthritis, we conducted a genome-wide
association study meta-analysis of 5,539 autoantibody-positive individuals with rheumatoid …

Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells

J Wang, A Ioan‐Facsinay… - European journal of …, 2007 - Wiley Online Library
Foxp3 plays a key role in CD4+ CD25+ Treg cell function in mice and represents a specific
marker for these cells. Despite the strong association between FOXP3 expression and …

Genetic influence on cytokine production and fatal meningococcal disease

RGJ Westendorp, JAM Langermans, TWJ Huizinga… - The Lancet, 1997 - thelancet.com
Background To assess the genetic influence on cytokine production and its contribution to
fatal outcome, we determined the capacity to produce tumour necrosis factor-α (TNFα) and …

Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA–DRB1 shared epitope for antibodies to citrullinated proteins

TWJ Huizinga, CI Amos… - Arthritis & …, 2005 - Wiley Online Library
Objective The main genetic risk factor for rheumatoid arthritis (RA), the HLA region, has
been known for 25 years. Previous research has demonstrated, within the RA population, an …